Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates-a multicentre, observational survey in critically ill patients

International Journal of Antimicrobial Agents

Volumn 35, Issue 4, 2010, Pages 375-381

  Vogelaers, Dirk ^a   De Bels, David ^b   Forêt, Frédéric ^c   Cran, Sophie ^d   Gilbert, Eric ^e   Schoonheydt, Karen ^f   Blot, Stijn ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^c CHR St Joseph Warquignies ^*  (Belgium)

^d Centre Hospitalier interregional Edith Cavell   (Belgium)

^e Intensive Care Department   (Belgium)

^f Intensive Care Department   (Belgium)

Author keywords

Antibiotic resistance; Appropriate therapy; Infection; Intensive care; Multidrug resistance

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; FLUCONAZOLE; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TEMOCILLIN; VANCOMYCIN;

ABDOMINAL INFECTION; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BLOODSTREAM INFECTION; CLINICAL TRIAL; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY; MULTIDRUG RESISTANCE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CRITICAL ILLNESS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERITONITIS; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77049125905     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.11.015     Document Type: Article

References (59)

1. Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin Microbiol Infect 14 (2008) 5-13
2. Lorente L., Blot S., and Rello J. Evidence on measures for the prevention of ventilator-associated pneumonia. Eur Respir J 30 (2007) 1193-1207
3. Masterton R.G., Mifsud A.J., and Rao G.G. Review of hospital isolation and infection control precautions. J Hosp Infect 54 (2003) 171-173
4. Labeau S.O., Vandijck D.M., Rello J., Adam S., Rosa A., Wenisch C., et al. Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit Care Med 37 (2009) 320-323
5. Labeau S., Vandijck D., Rello J., Adam S., Rosa A., Wenisch C., et al. Evidence-based guidelines for the prevention of ventilator-associated pneumonia: results of a knowledge test among European intensive care nurses. J Hosp Infect 70 (2008) 180-185
6. Yokoe D.S., and Classen D. Improving patient safety through infection control: a new healthcare imperative. Infect Control Hosp Epidemiol 29 Suppl. 1 (2008) S3-S11
7. Berwick D.M., Calkins D.R., McCannon C.J., and Hackbarth A.D. The 100,000 lives campaign: setting a goal and a deadline for improving health care quality. JAMA 295 (2006) 324-327
8. van der Kooi T.I., de Boer A.S., Mannien J., Wille J.C., Beaumont M.T., Mooi B.W., et al. Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med 33 (2007) 271-278
9. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., et al. The prevalence of nosocomial infection in intensive care units in Europe Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274 (1995) 639-644
10. Blot S.I., Depuydt P., Annemans L., Benoit D., Hoste E., De Waele J.J., et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 41 (2005) 1591-1598
11. Vander Stichele R.H., Elseviers M.M., Ferech M., Blot S., and Goossens H. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 58 (2006) 159-167
12. Vandijck D.M., Depaemelaere M., Labeau S.O., Depuydt P.O., Annemans L., Buyle F.M., et al. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection. Int J Antimicrob Agents 31 (2008) 161-165
13. Safdar N., Dezfulian C., Collard H.R., and Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33 (2005) 2184-2193
14. Blot S., Vandewoude K., Hoste E., and Colardyn F. Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa. J Hosp Infect 53 (2003) 18-24
15. Blot S., Vandewoude K., Hoste E., De Waele J., Kint K., Rosiers F., et al. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia. Infect Control Hosp Epidemiol 24 (2003) 912-915
16. Garrouste-Orgeas M., Timsit J.F., Tafflet M., Misset B., Zahar J.R., Soufir L., et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 42 (2006) 1118-1126
17. Blot S.I., Vandewoude K.H., and Colardyn F.A. Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients. Eur J Clin Microbiol Infect Dis 21 (2002) 471-473
18. Blot S.I., Vandewoude K.H., and Colardyn F.A. Evaluation of outcome in critically ill patients with nosocomial Enterobacter bacteremia: results of a matched cohort study. Chest 123 (2003) 1208-1213
19. Blot S., Cankurtaran M., Petrovic M., Vandijck D., Lizy C., Decruyenaere J., et al. Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: a comparison between middle-aged, old, and very old patients. Crit Care Med 37 (2009) 1634-1641
20. Agbaht K., Diaz E., Munoz E., Lisboa T., Gomez F., Depuydt P.O., et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med 35 (2007) 2064-2070
21. Vandewoude K.H., Blot S.I., Benoit D., Colardyn F., and Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect 56 (2004) 269-276
22. Harbarth S., Garbino J., Pugin J., Romand J.A., Lew D., and Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115 (2003) 529-535
23. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., and Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 146-155
24. Kollef M.H., Sherman G., Ward S., and Fraser V.J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115 (1999) 462-474
25. Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006) 1589-1596
26. Masterton R., Drusano G., Paterson D.L., and Park G. Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges. J Hosp Infect 55 Suppl. 1 (2003) 1-12
27. Depuydt P., Benoit D., Vogelaers D., Claeys G., Verschraegen G., Vandewoude K., et al. Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med 32 (2006) 1773-1781
28. Jung B., Sebbane M., Chanques G., Courouble P., Verzilli D., Perrigault P.F., et al. Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia. Intensive Care Med 35 (2009) 101-107
29. Depuydt P., Benoit D., Vogelaers D., Decruyenaere J., Vandijck D., Claeys G., et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 34 (2008) 675-682
30. Blot S., Depuydt P., Vogelaers D., Decruyenaere J., De Waele J., Hoste E., et al. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in an intensive care unit. Infect Control Hosp Epidemiol 26 (2005) 575-579
31. Papadomichelakis E., Kontopidou F., Antoniadou A., Poulakou G., Koratzanis E., Kopterides P., et al. Screening for resistant Gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med 34 (2008) 2169-2175
32. Depuydt P.O., Blot S.I., Benoit D.D., Claeys G.W., Verschraegen G.L., Vandewoude K.H., et al. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med 34 (2006) 653-659
33. Michel F., Franceschini B., Berger P., Arnal J.M., Gainnier M., Sainty J.M., et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 127 (2005) 589-597
34. Sandiumenge A., Diaz E., Bodí M., and Rello J. Therapy of ventilator-associated pneumonia. A patients-based approach based on the ten rules of "The Tarragona Strategy". Intensive Care Med 29 (2003) 876-883
35. Kollef M.H. Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Crit Care Med 29 (2001) 1473-1475
36. Leone M., Garcin F., Bouvenot J., Boyadjev I., Visintini P., Albanese J., et al. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med 35 (2007) 379-385 [Quiz:86]
37. Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs 63 (2003) 2157-2168
38. Kollef M.H. Treatment of ventilator-associated pneumonia: get it right from the start. Crit Care Med 31 (2003) 969-970
39. Rello J., Vidaur L., Sandiumenge A., Rodriguez A., Gualis B., Boque C., et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 32 (2004) 2183-2190
40. Leone M., and Martin C. How to break the vicious circle of antibiotic resistances?. Curr Opin Crit Care 14 (2008) 587-592
41. Masterton R.G. The new treatment paradigm and the role of carbapenems. Int J Antimicrob Agents 33 (2009) 105-110
42. Calandra T., and Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33 (2005) 1538-1548
43. Blot S., and Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs 64 (2004) 2159-2175
44. Vandewoude K.H., Blot S.I., Depuydt P., Benoit D., Temmerman W., Colardyn F., et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10 (2006) R31
45. Blot S., Vandewoude K., De Bacquer D., and Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 34 (2002) 1600-1606
46. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
47. Giamarellos-Bourboulis E.J., Papadimitriou E., Galanakis N., Antonopoulou A., Tsaganos T., Kanellakopoulou K., et al. Multidrug resistance to antimicrobials as a predominant factor influencing patient survival. Int J Antimicrob Agents 27 (2006) 476-481
48. Leone M., Bourgoin A., Cambon S., Dubuc M., Albanese J., and Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 31 (2003) 462-467
49. Ortega M., Marco F., Soriano A., Almela M., Martinez J.A., Munoz A., et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 63 (2009) 568-574
50. Kollef K.E., Schramm G.E., Wills A.R., Reichley R.M., Micek S.T., and Kollef M.H. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 134 (2008) 281-287
51. Albrecht S.J., Fishman N.O., Kitchen J., Nachamkin I., Bilker W.B., Hoegg C., et al. Reemergence of Gram-negative health care-associated bloodstream infections. Arch Intern Med 166 (2006) 1289-1294
52. Lautenbach E., and Polk R.E. Resistant gram-negative bacilli: a neglected healthcare crisis?. Am J Health Syst Pharm 64 (2007) S3-S21 [Quiz: S2-4]
53. Trouillet J.L., Chastre J., Vuagnat A., Joly-Guillou M.L., Combaux D., Dombret M.C., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157 (1998) 531-539
54. De Gheldre Y., Glupczynski Y., Struelens M., and De Mol P. Emergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals. Clin Microbiol Infect 5 (1999) 622-627
55. De Gheldre Y., Struelens M.J., Glupczynski Y., De Mol P., Maes N., Nonhoff C., et al. National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J Clin Microbiol 39 (2001) 889-896
56. Baran G., Erbay A., Bodur H., Onguru P., Akinci E., Balaban N., et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis 12 (2008) 16-21
57. Meyer E., Schwab F., Gastmeier P., Rueden H., Daschner F.D., and Jonas D. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). J Hosp Infect 64 (2006) 238-243
58. Degoricija V., Sharma M., Legac A., Gradiser M., Sefer S., and Vucicevic Z. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy. Croat Med J 47 (2006) 385-397
59. Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., Cohen J., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30 (2004) 536-555